IMC Chicago’s iShares US Medical Devices ETF IHI Stock Holding History

IMC Chicago’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,066	Closed	-$270K	–	6547
2026 Q1	$270K	Sell	5,066 -8,627	-63%	-$507K	﹤0.01%	4712
2025 Q4	$851K	Buy	+13,693	New	+$845K	﹤0.01%	3113

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

IMC Chicago's IHI Position: Q2 2026 in Review

IMC Chicago sold out of iShares US Medical Devices ETF (IHI) in Q2 2026, closing a stake of 5,066 shares — an estimated $270K sold.

IMC Chicago first reported a position in IHI in Q4 2025 and held it in 2 quarters. The position peaked at $851K in Q4 2025. 501 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

IMC Chicago reported no remaining iShares US Medical Devices ETF position as of Q2 2026 after selling out during the quarter.
IMC Chicago sold 5,066 iShares US Medical Devices ETF shares in Q2 2026, an estimated $270K.
IMC Chicago first reported a position in iShares US Medical Devices ETF in Q4 2025 and held it in 2 quarters.
IMC Chicago's iShares US Medical Devices ETF position peaked at $851K in Q4 2025.
501 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.